Company Filing History:
1 out of 12 
1 out of 1 Years Active: 2013
Title: Krishnamurti De Morais Carvalho: Innovator in Analgesic Treatments
Introduction
Krishnamurti De Morais Carvalho is a notable inventor based in Fortaleza, Brazil. He has made significant contributions to the field of medicine, particularly in the development of analgesic treatments. His innovative approach focuses on utilizing telocinobufagin, a compound derived from the skin of certain toads, for pain management.
Latest Patents
Krishnamurti holds a patent for the use of telocinobufagin as an analgesic in the treatment of acute and chronic pains. This invention is directed towards the manufacture of a medicament that effectively treats or prevents pain. The pharmaceutical composition comprises an effective amount of telocinobufagin, which has been shown to induce analgesia in both humans and animals. Notably, in vivo assays indicate that telocinobufagin is more potent than morphine, without the common side effects associated with opioids. Furthermore, studies have demonstrated that telocinobufagin does not exhibit cardiotoxicity, making it a promising alternative for pain relief.
Career Highlights
Throughout his career, Krishnamurti has worked with several reputable companies, including Cristalia Produtos Quimicos Farmaceuticos Ltda. and Genpharma Consultoria Farmaceutica e Genetica Ltda. His work in these organizations has contributed to advancements in pharmaceutical research and development.
Collaborations
Krishnamurti has collaborated with notable individuals in his field, including Dòris Maria Fernandes Carvalho and Maria Denise Fernandes Carvalho. These partnerships have fostered innovation and have been instrumental in the progress of his research.
Conclusion
Krishnamurti De Morais Carvalho is a pioneering inventor whose work in analgesic treatments has the potential to transform pain management. His innovative use of telocinobufagin offers a promising alternative to traditional pain relief methods.